← Product Code [MHX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX) · K061379

# INFINITY TELESMART TELEMETRY SYSTEM (K061379)

_Draeger Medical Systems, Inc. · MHX · Feb 16, 2007 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K061379

## Device Facts

- **Applicant:** Draeger Medical Systems, Inc.
- **Product Code:** [MHX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX.md)
- **Decision Date:** Feb 16, 2007
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.1025
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular

## Indications for Use

The INFINITY TeleSmart is a patient-worn transceiver (PWT) that is derived from miniaturization of the INFINITY ALPHA patient monitor. This new device performs telemetry monitoring of ambulatory and non-ambulatory patients, using the same algorithms that are incorporated in the INFINITY ALPHA.

## Device Story

Patient-worn transceiver (PWT) for ambulatory/non-ambulatory telemetry monitoring; miniaturized version of Infinity Alpha monitor. Inputs: physiological signals (ECG, SpO2, pulse rate). Processing: utilizes same algorithms as Infinity Alpha for arrhythmia and ST segment detection. Output: physiological data and alarms transmitted to central monitoring station. Used in clinical settings; operated by healthcare professionals. Benefits: enables continuous patient monitoring while allowing mobility.

## Clinical Evidence

No clinical data generated for this submission; equivalence established via non-clinical performance data and comparison to predicate devices.

## Technological Characteristics

Patient-worn transceiver (PWT); miniaturized form factor; utilizes same algorithms as Infinity Alpha; wireless physiological signal transmission; Class II device.

## Regulatory Identification

The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.

## Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.

## Predicate Devices

- Infinity MultiView Workstation Telemetry ([K024108](/device/K024108.md))
- Infinity Alpha ([K051658](/device/K051658.md))

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

g lofr

661399

510(k) SUMMARY as required per 807.92(c)

1. Submitter's Name and Address:

Draeger Medical Systems, Inc. 6 Tech Drive Andover, MA 01810

FEB 1 6 2007

Charles C. Morganson, Jr., Manager Regulatory Affairs Tel: (978) 379-8309 Fax: (978) 379-8333

Date submission was prepared:

Contact Person:

May 17, 2006

2. Trade Name, Common Name and Classification Name:

A. Trade Name:

Infinity TeleSmart Telemetry System

B. Common Name, Classification Name, Class and Regulation Number:

| Common Name                                                               | Classification Number | Class | Regulation Number |
|---------------------------------------------------------------------------|-----------------------|-------|-------------------|
| Detector and Alarm                                                        | 74DSI                 | II    | 21 CFR 870.1025   |
| Monitor, Physiological,<br>Patient (with Arrhythmia<br>Detector or Alarms | 74MHX                 | II    | 21 CFR 870.1025   |
| Cardiac Monitor                                                           | 74DRT                 | II    | 21 CFR 870.2300   |
| ST Segment Monitor with<br>Alarm                                          | 74MLD                 | II    | 21 CFR 870.1025   |
| Pulse Oximeter                                                            | 74DQA                 | II    | 21 CFR 870.2700   |
| Pulse Rate Monitor                                                        | 74BWS                 | II    | 21 CFR 870.2300   |
| System, Network and<br>Communication,<br>Physiological Monitors           | 74MSX                 | II    | 21 CFR 870.2300   |
| Radiofrequency Physiological<br>Signal Transmitter and<br>Receiver        | 74DRG                 | II    | 21 CFR 870.2910   |

3. Predicate Device Identification:

Infinity MultiView Workstation Telemetry K024108

K051658 Infinity Alpha

{1}------------------------------------------------

## 4. Device Description:

The INFINITY TeleSmart is a patient-worn transceiver (PWT) that is derived from miniaturization of the INFINITY ALPHA patient monitor. This new device performs telemetry monitoring of ambulatory and non-ambulatory patients, using the same algorithms that are incorporated in the INFINITY ALPHA.

2 of 2

5. Comparison to Predicate Device:

The Infinity TeleSmart Telemetry System is substantially equivalent to the Infinity MultiView Workstation Telemetry cleared for market under 510(k) K024108 and Infinity Alpha, 510(k) K051658.

6. Assessment of non-clinical performance data for equivalence:

Refer to section 10

7. Assessment of clinical performance data for equivalence:

Was not generated for this submission

8 Biocompatibility:

Not applicable

9.Sterilization:

Not applicable

10. Standards and Guidance's:

Refer to section 10

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K061379](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/MHX/K061379)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
